Skip to content

Advanced Sperm Selection Techniques and Their Contribution to Blastocyst Euploidy Rates

Advanced Sperm Selection Techniques and Their Contribution to Blastocyst Euploidy Rates

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05494216
Enrollment
515
Registered
2022-08-09
Start date
2022-08-01
Completion date
2024-01-01
Last updated
2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Sperm DNA Fragmentation

Keywords

Sperm selection, PICSI, MACS, Sperm DNA fragmentation, PGT-A, Euploidy rate

Brief summary

Comparing different advanced sperm selection techniques like Physiological ICSI (PICSI) and magnetic activated cell sorting (MACS) in terms of the PGT-A outcomes of each arm blastocysts

Detailed description

Advanced sperm selection methods like PICSI and MACS have been developed for selecting a healthy mature non apoptotic sperm with lower Sperm DNA fragmentation. Previous studies compared the pre-implantation embryo development parameters of those techniques, but none looked at comparing the PGT-A results or euploidy rates of the blastocysts derived from each sperm selection. PGT-A cases will be randomized on the day of ICSI to the 2 assigned sperm selection techniques.

Interventions

OTHERPICSI

Sperm selection using PICSI dish for selecting sperm with lower DNA fragmentation index

OTHERMACS

Sperm selection using MACS for selecting sperm with lower DNA fragmentation index

Sponsors

Ganin Fertility Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Case must have PGT-A for all of her blastocysts * Males diagnosed with abnormal sperm DNA fragmentation index (\> 20%). * Normo responder (\> 5 mature oocytes) * Male will have to refrain from ejaculation no less than 1 day but no greater than 3 days prior semen specimen production on day of ICSI

Exclusion criteria

* Leukocytospermia * Presence of varicocele. * Known genetic abnormality * Use of sperm or oocyte donors * Use of gestational carrier * Presence of any of the endometrial factors that affect embryo implantation such as hydrosalpings, adenomyosis or previous uterine infection * Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation

Design outcomes

Primary

MeasureTime frameDescription
High mosaic rate15 days post ICSIDefined as the proportion of high mosaic blastocysts
Euploidy rate15 days post ICSIDefined as the proportion of euploid blastocysts
Aneuploidy rate15 days post ICSIDefined as the proportion of aneuploid blastocysts
Low mosaic rate15 days post ICSIDefined as the proportion of low mosaic blastocysts

Secondary

MeasureTime frameDescription
Fertilization rate1 dayDefined as the proportion of fertilizaed oocytes
Cleavage rate3 daysDefined as the proportion of cleaved embryos on day 3
Blastocyst development rate5-6 daysDefined as the proportion of blastocysts formed on day 5 or 6
Blastocyst quality rate5-6 daysDefined as the assessment of blastocyst quality according to Gardner's criteria into: good, fair or poor

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026